Sharun Khan: Advancing Regenerative Medicine Through Veterinary Translational Science
Sharun Khan, Postdoctoral Fellow at Regenerative Medicine AAU, Marie SkΕodowska-Curie Actions Postdoctoral Fellow at Aalborg Universit, shared a post on LinkedIn:
”Excited to share the publication of our new book, ‘ππ₯ππππ₯ππ ππ’ππ‘ ππ₯ππ¬π¦π π’π§ πππππ«π’π§ππ«π² πππ ππ§ππ«πππ’π―π ππππ’ππ’π§π’
Regenerative medicine is often viewed through the lens of human healthcare, but many transformative advances begin with understanding how therapies perform in veterinary patients.
Unlike experimental laboratory models, veterinary patients develop naturally occurring diseases such as osteoarthritis, tendon injuries, chronic wounds, and ocular disorders.
These spontaneous conditions closely mirror the complexity, heterogeneity, and progression of diseases encountered in humans.
As a result, veterinary medicine occupies a unique position at the interface between basic science and clinical translation.
As researchers passionate about regenerative medicine, Amitha Banu Shajahan and I wanted to create a resource that bridges science and clinical practice.
We were fortunate to collaborate with an exceptional international group of experts who helped make this vision a reality.
We hope this book not only serves the veterinary community but also highlights the critical role of veterinary regenerative medicine in shaping the future of regenerative therapies for both animals and humans.
A sincere thank you to all contributing authors, collaborators, and Springer for making this project possible.”
Stay updated with Hemostasis Today:
-
Aug 16, 2026, 15:14Waqas Ahmed: Iron-Enriched Yeast Offers a New Approach to Iron Deficiency
-
Aug 16, 2026, 15:11Grace Yau: Inhalable Platelet Lysate Opens New Possibilities for Pulmonary Therapy
-
Aug 16, 2026, 14:52Connie Montgomery: Enjoyed My Opportunity to Facilitate and Speak at BDC 2026
-
Aug 16, 2026, 14:47Targeted Outside-In Signaling Inhibition – Dissociating Thrombosis from Hemostasis – JTH
-
Aug 16, 2026, 14:38Christopher Hanson: Broad-Spectrum Platelet Inhibition via Non-Odorant OR2L13 Agonists
-
Aug 16, 2026, 14:27Preeti Verma: The Case of the Missing Clue – Why Databases Need a Clinicianβs Eye
-
Aug 16, 2026, 14:22FDA Licenses First Freeze-Dried Plasma Product in the United States
-
Aug 16, 2026, 14:20Christopher Cannon: Discontinuation vs. Continuation of Statin Therapy in Adults Aged Under 75
-
Aug 16, 2026, 13:53Honey Blankenship: United by a Shared Commitment to the Bleeding Disorders Community